US20020197828A1 - Method and apparatus for manufacturing a semiconductor device and processing a substrate - Google Patents

Method and apparatus for manufacturing a semiconductor device and processing a substrate Download PDF

Info

Publication number
US20020197828A1
US20020197828A1 US10/106,234 US10623402A US2002197828A1 US 20020197828 A1 US20020197828 A1 US 20020197828A1 US 10623402 A US10623402 A US 10623402A US 2002197828 A1 US2002197828 A1 US 2002197828A1
Authority
US
United States
Prior art keywords
substrate
film
tantalum oxide
oxide film
processing chamber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/106,234
Inventor
Masayuki Asai
Tsutomu Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Kokusai Electric Inc
Original Assignee
Hitachi Kokusai Electric Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Kokusai Electric Inc filed Critical Hitachi Kokusai Electric Inc
Assigned to HITACHI KOKUSAI ELECTRIC INC. reassignment HITACHI KOKUSAI ELECTRIC INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ASAI, MASAYUKI, TANAKA, TSUTOMU
Publication of US20020197828A1 publication Critical patent/US20020197828A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04BTRANSMISSION
    • H04B10/00Transmission systems employing electromagnetic waves other than radio-waves, e.g. infrared, visible or ultraviolet light, or employing corpuscular radiation, e.g. quantum communication
    • H04B10/29Repeaters
    • H04B10/291Repeaters in which processing or amplification is carried out without conversion of the main signal from optical form
    • H04B10/293Signal power control
    • H04B10/294Signal power control in a multiwavelength system, e.g. gain equalisation
    • H04B10/296Transient power control, e.g. due to channel add/drop or rapid fluctuations in the input power
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • C23C16/40Oxides
    • C23C16/405Oxides of refractory metals or yttrium
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/44Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
    • C23C16/4401Means for minimising impurities, e.g. dust, moisture or residual gas, in the reaction chamber
    • C23C16/4405Cleaning of reactor or parts inside the reactor by using reactive gases
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/44Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
    • C23C16/54Apparatus specially adapted for continuous coating
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/56After-treatment

Definitions

  • the present invention relates to a method and apparatus for manufacturing a semiconductor device and processing a substrate.
  • FIG. 5 shows a schematic view of a conventional chemical vapor deposition (CVD) apparatus 50 for use in processing a substrate.
  • the apparatus 50 includes a heater 2 installed in a reactor chamber (hereinafter also referred to as a processing chamber) 1 , a susceptor 3 positioned above the heater 2 , a shower head 5 having shower holes 6 and installed above the susceptor 3 , a gas inlet 7 jointed above the shower head 5 , and an exhaust port 8 provided at the processing chamber 1 .
  • a reactor chamber hereinafter also referred to as a processing chamber
  • a susceptor 3 positioned above the heater 2
  • a shower head 5 having shower holes 6 and installed above the susceptor 3
  • a gas inlet 7 jointed above the shower head 5
  • an exhaust port 8 provided at the processing chamber 1 .
  • a substrate 4 is mounted on the susceptor 3 positioned in the hermetically sealed processing chamber 1 and is heated by the heater 2 .
  • a reactive gas obtained by mixing an evaporated Penta Ethoxy Tantalum (Ta(OC 2 H 5 ) 5 , hereinafter referred to as PET), an oxygen gas and an inert gas is supplied to the substrate 4 after passing through the gas inlet 7 and the shower head 5 .
  • a tantalum oxide film is then formed on minute electrical circuit patterns positioned on the substrate 4 by the chemical reaction of the reactive gas that takes place on the substrate 4 .
  • an exhausted gas is pumped out from the processing chamber 1 via the exhaust port 8 .
  • FIG. 6 there is illustrated a tantalum oxide film 11 grown on the substrate 4 with a step coverage (b/a), a and b representing a film thickness on the top surface of the substrate 4 and that on the bottom of a recess of the substrate 4 , respectively.
  • FIG. 7 shows the relationship between a step coverage (b/a) and the substrate temperature during the film growth (referred to as film growth temperature hereinafter).
  • the step coverage of the tantalum oxide film 11 is good as shown in FIG. 7 and the tantalum oxide film 11 becomes an amorphous tantalum oxide film (TaO film).
  • the film growth temperature is high, the step coverage of the tantalum oxide film 11 is poor and the tantalum oxide film 11 becomes a crystalline tantalum oxide film (Ta 2 O 5 film).
  • the film growth temperature is low, e.g., around 440° C., no significant stress is induced in the grown tantalum oxide film 11 and, therefore, the thus grown tantalum oxide film can be crystallized without much suffering from crack development therein during the subsequent recrystallization process.
  • a crystalline tantalum oxide film having good step coverage is obtained by way of employing a two step process. That is, an amorphous tantalum oxide film 11 is formed first on the substrate 4 at a relatively low film growth temperature, e.g., near 440° C., by using, e.g., the CVD apparatus 50 shown in FIG. 5. Thereafter, a rapid thermal oxidation (RTO) process is carried out on the thus grown amorphous tantalum oxide film at about 650° C. to 800° C. in an O 2 atmosphere to obtain the crystalline tantalum oxide film with a good step coverage.
  • RTO rapid thermal oxidation
  • FIG. 8 depicts a relationship between the film growth temperature and the content of impurities, such as carbon and hydrogen, introduced in the tantalum oxide film 11 .
  • impurities such as carbon and hydrogen
  • a tantalum oxide film having a predetermined thickness by repeatedly forming a relatively thin amorphous tantalum oxide film and carrying out the RTO process thereon sequentially multiple times.
  • RPO remote plasma oxidation
  • FIG. 9 schematically shows a conventional substrate processing apparatus 90 capable of performing the CVD process, the RPO process and the RTO process described above.
  • the substrate processing apparatus 90 is provided with a load lock chamber 21 , a substrate transfer chamber 25 , a CVD processing chamber (reaction chamber) 22 identical to that shown in FIG. 5, an RPO processing chamber 23 and an RTO processing chamber 24 .
  • Arrows represent various substrate transfer paths.
  • the substrate 4 is transferred from the load lock chamber 21 to the CVD processing chamber 22 in which the amorphous tantalum oxide film is formed on the substrate 4 . Thereafter, the substrate 4 having the amorphous tantalum oxide film thereon is transferred from the CVD processing chamber 22 to the RPO processing chamber 23 . In the RPO processing chamber 23 , the RPO process is carried out on the amorphous tantalum oxide film. The thus processed substrate 4 is then transferred from the RPO processing chamber 23 to the RTO processing chamber 24 . After carrying out the RTO process in the RTO processing chamber 24 , the substrate 4 is taken out from the substrate processing apparatus 90 via the load lock chamber 21 . By employing such a substrate processing apparatus 90 , a crystalline tantalum oxide film having a small amount of impurities such as carbon, hydrogen and the like can be formed on the substrate 4 .
  • the amorphous tantalum oxide film formation and the RTO are carried out in a same reaction chamber, e.g., the processing chamber 1 of the CVD apparatus 50 shown in FIG. 5, the amorphous tantalum oxide formed outside the substrate 4 , e.g., on the wall of the processing chamber 1 or the shower head 5 , during the amorphous tantalum oxide film deposition process may also be crystallized by the RTO process and then thus crystallized tantalum oxide may be peeled off to fall down on the substrate 4 . Accordingly, the separate CVD and RTO processing chambers need be prepared as shown in FIG. 9.
  • the substrate 4 need be repeatedly transferred between the CVD processing chamber and the RTO processing chamber and, therefore, the crystalline tantalum oxide film on the substrate 4 cannot be produced in an efficient manner.
  • the substrate 4 also need be repeatedly transferred among the CVD processing chamber 22 , the RPO processing chamber 23 and the RTO processing chamber 24 , lowering the system efficiency and deteriorating the throughput of the substrate processing apparatus.
  • a method for manufacturing a semiconductor device including the steps of: (a) forming an amorphous film on a substrate; (b) removing at least a portion of an impurity element included in the amorphous film; and (c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
  • a method for processing a substrate including the steps of: (a) forming an amorphous film on a substrate; (b) removing at least a portion of an impurity element included in the amorphous film; and (c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
  • an apparatus for processing a substrate including: a processing chamber for processing a substrate; a gas supply unit for providing a reactive gas into the processing chamber; a plasma generation unit; and a control unit, wherein the control unit controls the substrate processing apparatus to sequentially repeat, in the processing chamber, a film forming process for depositing an amorphous film on the substrate through the use of the reactive gas and a plasma process for removing at least a portion of an impurity element included in the amorphous film through the use of the plasma generation unit.
  • FIG. 1 schematically illustrates a CVD apparatus in accordance with the present invention
  • FIG. 2 depicts the relationship between the number of process cycles and the content of impurities included in an amorphous tantalum oxide film
  • FIG. 3 presents the relationship between the number of process cycles and a leak current of a crystallized tantalum oxide film
  • FIG. 4 schematically represents a substrate processing apparatus in accordance with the present invention
  • FIG. 5 schematically shows a conventional CVD apparatus
  • FIG. 6 sets forth a cross sectional view of a tantalum oxide film grown on a substrate
  • FIG. 7 shows the relationship between the step coverage and the film growth temperature
  • FIG. 8 depicts the relationship between the film growth temperature and the content of impurities included in a tantalum oxide film
  • FIG. 9 schematically shows a conventional substrate processing apparatus.
  • FIG. 1 schematically illustrates a CVD apparatus 10 in accordance with the present invention.
  • a heater 32 is installed in a reactor chamber (hereinafter also referred to as a processing chamber) 31 .
  • a substrate rotating unit 33 is installed outside the processing chamber 31 .
  • a susceptor 34 rotated by the substrate rotating unit 33 is installed in the processing chamber 31 .
  • the susceptor 34 is positioned on the heater 32 .
  • a substrate 35 e.g., wafer
  • a shower head 36 having shower holes 37 is installed above the susceptor 34 .
  • a reactive gas supply unit 38 is installed outside the processing chamber 31 .
  • a gas supply line 39 connects the reactive gas supply unit 38 to the shower head 36 and has a valve 40 .
  • a reactive gas is supplied to the processing chamber 31 via shower holes 37 after passing through the gas supply line 39 and the shower head 36 .
  • a RPO unit (plasma generating apparatus) 41 is installed outside the processing chamber 31 .
  • a gas supply line 42 connects the RPO unit 41 with the shower head 36 and has a valve 43 .
  • an exhaust line (exhaust port) 44 is installed at lower side wall of the processing chamber 31 .
  • a control unit 45 is provided outside the processing chamber 31 .
  • the control unit 45 serves to control the CVD apparatus 10 to repeatedly perform process cycles of a film forming process and a RPO process as many times as desired in the processing chamber 31 .
  • an amorphous (non-crystalline) tantalum oxide film is grown on the substrate 35 and during the RPO process, specific elements such as carbon and hydrogen included in the thus grown amorphous tantalum oxide film are removed or reduced in their amount by the plasma process through the use of the RPO unit 41 .
  • FIG. 1 there will be described a method for manufacturing a semiconductor device and processing a substrate by using the CVD apparatus 10 in accordance with the present invention.
  • the substrate 35 is loaded on the susceptor. 34 positioned in the processing chamber 31 .
  • the susceptor 34 is then rotated by the substrate rotating unit 33 and the substrate 35 is heated at about 440° C. by the heater 32 .
  • the valve 40 is opened to supply the substrate 35 with a reactive gas containing the mixture of an evaporated PET, an oxygen gas and an inert gas via the gas supply line 39 and the shower head 36 , thereby forming an amorphous tantalum oxide film having a thickness of about 20 ⁇ grown on the substrate 35 (film growing process).
  • valve 40 is closed to stop the reactive gas supply while maintaining the same condition in which the substrate 35 is rotated and heated at about 440° C.
  • valve 43 is opened to introduce oxygen radicals generated from the RPO unit 41 on the substrate 35 though the gas supply line 42 and the shower head 36 to thereby carry out the RPO process on the thus grown amorphous tantalum oxide film (impurity removing process). Consequently, the film growing process and the impurity removing process are sequentially carried out in one processing chamber, i.e., the processing chamber 31 .
  • both the film growing process and the impurity removing process are carried out at a substantially same temperature. That is to say, it is preferable that the setting temperature of the heater is maintained constant during the film growing process and the impurity removing process as well. By maintaining a constant temperature or greatly reducing a temperature variation in the processing chamber, particle generation due to thermal expansion of such parts as the shower head or the susceptor in the processing chamber can be suppressed and metal contamination originating from a metallic part in the processing chamber can also be prevented. In view of particulate generation discussed above, it is also preferable that both the film growing process and the impurity removing process are carried out at a constant pressure.
  • An amorphous tantalum oxide film having a thickness of about 80 ⁇ can be formed by repeatedly performing four times the process cycle where one film forming process and one RPO process are carried out sequentially. That is, the film growing process and the impurity removing process are sequentially repeated a predetermined number of times by controlling the valves 40 , 43 through the use of the control unit 45 . Thereafter, the thus processed amorphous tantalum oxide film is treated to provide a crystalline tantalum oxide film by carrying out a RTO process thereon in a RTO process unit (not shown).
  • the RPO process is carried out on the amorphous tantalum oxide film having a thickness of 20 ⁇ , i.e., a quarter of the final thickness of 80 ⁇ . Since such impurities as C and H can be removed or reduced more rapidly and uniformly from a thinner film by the RPO process, the amorphous tantalum oxide film having a predetermined final thickness with a low impurity content can be efficiently obtained by repeatedly performing the process cycles as described above.
  • the amorphous tantalum oxide film is thin and therefore has a reduced amount of impurities, when the RPO process is performed on the amorphous tantalum oxide film having the thickness of 20 ⁇ , i.e., a quarter of the final thickness 80 ⁇ , less oxygen radicals are consumed at the entrance and the side wall of the groove, so that the sufficient amount of oxygen radicals can be uniformly supplied to the amorphous tantalum oxide film located at the bottom portion of the deep groove.
  • the amorphous tantalum oxide film having a predetermined target thickness with a low impurity concentration of C, H and the like can be readily formed since the impurities can be uniformly removed in a short time.
  • the amorphous tantalum oxide film is also formed on an inner wall of the processing chamber 31 and the shower head 36 . And as the film growing processes are repeated, the thickness of the accumulated film thereon becomes greater and so does the impurities such as C and H included in the accumulated film. As a result, more impurities are introduced in an amorphous tantalum oxide grown later, resulting in temporal variations in the amount of impurities contained in the amorphous tantalum oxide film formed on the substrate 35 .
  • the impurities included in the thin film previously deposited outside the substrate can also be immediately removed by the subsequent RPO process. Resultantly, accumulation of the impurities in the ever thickening TaO film deposited inside the processing chamber can be effectively prevented and a content of the impurities included in the amorphous tantalum oxide film formed on the substrate 35 can be maintained rather uniformly, without suffering from temporal variations.
  • an ALD (atomic layer deposition) scheme can be employed, in forming the amorphous tantalum film on the substrate.
  • the ALD differs from the conventional CVD in that in ALD atomic layers are formed one at a time at a lower substrate treating temperature (300° C. or below) and under a low inner pressure inside the processing chamber (10 Pa or below) and further only a surface reaction (adsorption reaction) is taking place.
  • the amorphous tantalum oxide film is formed by simultaneously growing tens of atomic layers, wherein the treating temperature of the substrate 35 is high (around 440° C.) and also the inner pressure of the processing chamber 31 is high (50 Pa or above) and further both the surface reaction and a vapor phase reaction are taking place.
  • the film growing process and the impurities removing process are carried out with the substrate 35 being rotated, the film growth and the removal of the impurities can be uniformly accomplished throughout the substrate 35 . Therefore, both the amorphous and the crystalline tantalum oxide film with the uniform film quality and low impurity concentration can be formed on the substrate 35 . Also, it is possible to efficiently remove the impurities from the amorphous tantalum oxide film without incurring any damage thereon since the impurity removing process is carried out by using the RPO process.
  • the crystallization process is carried out on the amorphous tantalum oxide film formed on the substrate 35 obtained by repeatedly performing the film forming process and the impurity removing process sequentially multiple times. Therefore, the crystalline tantalum oxide film having a good step coverage along with a low impurity concentration and good insulating properties can be efficiently formed on the substrate 35 . Further, the amorphous tantalum oxide film can be efficiently crystallized since the RTO process is employed in the crystallization process.
  • FIG. 2 depicts a relationship between the number of process cycles and the total amount of impurities included in a crystalline tantalum oxide film, wherein in each process cycle one amorphous tantalum oxide film growing process and one RPO process have been sequentially carried out in the CVD apparatus described in FIG. 1. As shown in FIG. 2, the content of impurities included in the crystalline tantalum oxide film decreases as the number of process cycles increases.
  • FIG. 3 presents a relationship between the number of process cycles and a leak current (A/cm 2 ) of a crystallized tantalum oxide film.
  • the leak current of the crystalline tantalum oxide film decreases as shown in FIG. 3 and the insulating properties thereof become improved as the number of process cycles increases.
  • FIG. 4 there is illustrated a substrate processing apparatus 40 in accordance with the present invention, including a load lock chamber 51 , a substrate transfer chamber 55 , CVD processing chambers 52 and 53 identical to that described in FIG. 1 and a RTO processing chamber 54 . Arrows represent various substrate transfer paths.
  • the substrate 35 is transferred from the load lock chamber 51 to the CVD processing chamber 52 or 53 , wherein the amorphous tantalum oxide film is formed on the substrate 35 by repeating the amorphous tantalum oxide film growing process and the RPO process sequentially a number of times. Thereafter, the substrate 35 having the amorphous tantalum oxide film thereon is transferred from the CVD processing chamber 52 or 53 to the RTO processing chamber 54 . After carrying out the RTO process in the RTO processing chamber 54 , the substrate 35 is taken out from the substrate processing apparatus 50 via the load lock chamber 51 .
  • the amorphous tantalum oxide film having a low impurity content of C, H and the like is formed on the substrate 35 by repeatedly performing the process cycles, in which the amorphous tantalum oxide film forming process and the RPO process are sequentially carried out multiple times. Further, the number of transfer processes per each substrate is three in the preferred substrate processing apparatus 40 shown in FIG. 4, while same is four in the conventional substrate processing apparatus 90 shown in FIG. 9. Therefore, the system efficiency and the throughput of product in accordance with the present invention can be improved, in comparison with the prior art substrate processing apparatus.
  • the present invention can also be applied in cases where other types of films are formed on a substrate by using other types of source materials.
  • the present invention can be advantageously applied to the case where an organic material is used as the source material of a film since the amount of impurities introduced in the grown film becomes large by the use of the organic material.

Abstract

A substrate processing apparatus includes a CVD (chemical vapor deposition) processing chamber and a RTO (rapid thermal oxidation) processing chamber. In the CVD processing chamber, a film growing process, in which thin amorphous film is deposited on a substrate, and an impurity removing process, in which specific impurities included in the grown amorphous film are removed, are repeatedly performed multiple times to provide an impurity removed amorphous film with good step coverage. Thus treated amorphous film on the substrate is then crystallized in the RTO process chamber to provide a crystalline film.

Description

    FIELD OF THE INVENTION
  • The present invention relates to a method and apparatus for manufacturing a semiconductor device and processing a substrate. [0001]
  • DESCRIPTION OF THE PRIOR ART
  • FIG. 5 shows a schematic view of a conventional chemical vapor deposition (CVD) [0002] apparatus 50 for use in processing a substrate. As shown in FIG. 5, the apparatus 50 includes a heater 2 installed in a reactor chamber (hereinafter also referred to as a processing chamber) 1, a susceptor 3 positioned above the heater 2, a shower head 5 having shower holes 6 and installed above the susceptor 3, a gas inlet 7 jointed above the shower head 5, and an exhaust port 8 provided at the processing chamber 1.
  • In the [0003] apparatus 50, a substrate 4 is mounted on the susceptor 3 positioned in the hermetically sealed processing chamber 1 and is heated by the heater 2. In the meantime, a reactive gas obtained by mixing an evaporated Penta Ethoxy Tantalum (Ta(OC2H5)5, hereinafter referred to as PET), an oxygen gas and an inert gas is supplied to the substrate 4 after passing through the gas inlet 7 and the shower head 5. A tantalum oxide film is then formed on minute electrical circuit patterns positioned on the substrate 4 by the chemical reaction of the reactive gas that takes place on the substrate 4. Also, an exhausted gas is pumped out from the processing chamber 1 via the exhaust port 8.
  • Referring to FIG. 6, there is illustrated a [0004] tantalum oxide film 11 grown on the substrate 4 with a step coverage (b/a), a and b representing a film thickness on the top surface of the substrate 4 and that on the bottom of a recess of the substrate 4, respectively. FIG. 7 shows the relationship between a step coverage (b/a) and the substrate temperature during the film growth (referred to as film growth temperature hereinafter).
  • In case the film growth temperature is low, the step coverage of the [0005] tantalum oxide film 11 is good as shown in FIG. 7 and the tantalum oxide film 11 becomes an amorphous tantalum oxide film (TaO film). On the other hand, when the film growth temperature is high, the step coverage of the tantalum oxide film 11 is poor and the tantalum oxide film 11 becomes a crystalline tantalum oxide film (Ta2O5 film). Also, if the film growth temperature is low, e.g., around 440° C., no significant stress is induced in the grown tantalum oxide film 11 and, therefore, the thus grown tantalum oxide film can be crystallized without much suffering from crack development therein during the subsequent recrystallization process.
  • For this reason, a crystalline tantalum oxide film having good step coverage is obtained by way of employing a two step process. That is, an amorphous [0006] tantalum oxide film 11 is formed first on the substrate 4 at a relatively low film growth temperature, e.g., near 440° C., by using, e.g., the CVD apparatus 50 shown in FIG. 5. Thereafter, a rapid thermal oxidation (RTO) process is carried out on the thus grown amorphous tantalum oxide film at about 650° C. to 800° C. in an O2 atmosphere to obtain the crystalline tantalum oxide film with a good step coverage.
  • FIG. 8 depicts a relationship between the film growth temperature and the content of impurities, such as carbon and hydrogen, introduced in the [0007] tantalum oxide film 11. In case where the film growth temperature is low, the growing tantalum oxide film 11 becomes amorphous and the content of impurities, such as carbon, hydrogen and the like introduced therein during the growth, increases.
  • In other words, when the amorphous tantalum oxide film is formed on the [0008] substrate 4, a large amount of impurities such as carbon, hydrogen and the like originated from the organic source material, e.g., PET, is introduced into the growing amorphous tantalum oxide film. Therefore, it may be necessary to remove the thus introduced impurities simultaneously during the RTO process described above.
  • Since, however, the crystallization of the amorphous tantalum oxide film carried out by the RTO process is initiated at the surface of the amorphous tantalum oxide film and progresses into the inner portion thereof, the impurities such as carbon, hydrogen and the like may not be effectively removed from the film. In other words, as the amorphous tantalum oxide film becomes crystallized, a mean distance between atoms constituting the film gets reduced and further voids or vacancies among the atoms constituting the film also diminishes. Accordingly, impurity atoms included inside the film cannot readily pass through the atoms of the crystallized tantalum oxide film formed at the surface region. As a result, it becomes difficult to remove the impurities remaining inside the tantalum oxide film once the crystallization takes place at the surface region thereof and, therefore, insulation properties of the crystallized tantalum oxide film are deteriorated. [0009]
  • Therefore, it may be preferable to form a tantalum oxide film having a predetermined thickness, by repeatedly forming a relatively thin amorphous tantalum oxide film and carrying out the RTO process thereon sequentially multiple times. [0010]
  • Further, it may be more preferable to subject the amorphous tantalum oxide film grown in the [0011] CVD apparatus 50 shown in FIG. 5 to a remote plasma oxidation (RPO) process to remove the impurities included in the film by oxygen radicals, followed by the RTO process described above.
  • FIG. 9 schematically shows a conventional [0012] substrate processing apparatus 90 capable of performing the CVD process, the RPO process and the RTO process described above. As shown in FIG. 9, the substrate processing apparatus 90 is provided with a load lock chamber 21, a substrate transfer chamber 25, a CVD processing chamber (reaction chamber) 22 identical to that shown in FIG. 5, an RPO processing chamber 23 and an RTO processing chamber 24. Arrows represent various substrate transfer paths.
  • In the [0013] substrate processing apparatus 90, the substrate 4 is transferred from the load lock chamber 21 to the CVD processing chamber 22 in which the amorphous tantalum oxide film is formed on the substrate 4. Thereafter, the substrate 4 having the amorphous tantalum oxide film thereon is transferred from the CVD processing chamber 22 to the RPO processing chamber 23. In the RPO processing chamber 23, the RPO process is carried out on the amorphous tantalum oxide film. The thus processed substrate 4 is then transferred from the RPO processing chamber 23 to the RTO processing chamber 24. After carrying out the RTO process in the RTO processing chamber 24, the substrate 4 is taken out from the substrate processing apparatus 90 via the load lock chamber 21. By employing such a substrate processing apparatus 90, a crystalline tantalum oxide film having a small amount of impurities such as carbon, hydrogen and the like can be formed on the substrate 4.
  • In case the amorphous tantalum oxide film formation and the RTO are carried out in a same reaction chamber, e.g., the [0014] processing chamber 1 of the CVD apparatus 50 shown in FIG. 5, the amorphous tantalum oxide formed outside the substrate 4, e.g., on the wall of the processing chamber 1 or the shower head 5, during the amorphous tantalum oxide film deposition process may also be crystallized by the RTO process and then thus crystallized tantalum oxide may be peeled off to fall down on the substrate 4. Accordingly, the separate CVD and RTO processing chambers need be prepared as shown in FIG. 9.
  • Therefore, in case where a crystalline tantalum oxide film is formed by repeatedly performing the amorphous tantalum oxide film deposition process and the RTO process sequentially, the [0015] substrate 4 need be repeatedly transferred between the CVD processing chamber and the RTO processing chamber and, therefore, the crystalline tantalum oxide film on the substrate 4 cannot be produced in an efficient manner.
  • Similarly, in the [0016] substrate processing apparatus 90, the substrate 4 also need be repeatedly transferred among the CVD processing chamber 22, the RPO processing chamber 23 and the RTO processing chamber 24, lowering the system efficiency and deteriorating the throughput of the substrate processing apparatus.
  • SUMMARY OF THE INVENTION
  • It is, therefore, an object of the present invention to provide a method and apparatus for manufacturing a semiconductor device and processing a substrate, capable of efficiently forming a film having low content of such impurities as carbon, hydrogen and the like on a substrate. [0017]
  • In accordance with one aspect of the invention, there is provided a method for manufacturing a semiconductor device, including the steps of: (a) forming an amorphous film on a substrate; (b) removing at least a portion of an impurity element included in the amorphous film; and (c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate. [0018]
  • In accordance with another aspect of the invention, there is provided a method for processing a substrate, including the steps of: (a) forming an amorphous film on a substrate; (b) removing at least a portion of an impurity element included in the amorphous film; and (c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate. [0019]
  • In accordance with still another aspect of the invention, there is provided an apparatus for processing a substrate, including: a processing chamber for processing a substrate; a gas supply unit for providing a reactive gas into the processing chamber; a plasma generation unit; and a control unit, wherein the control unit controls the substrate processing apparatus to sequentially repeat, in the processing chamber, a film forming process for depositing an amorphous film on the substrate through the use of the reactive gas and a plasma process for removing at least a portion of an impurity element included in the amorphous film through the use of the plasma generation unit.[0020]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The above and other objects and features of the present invention will become apparent from the following description given in conjunction with the accompanying drawings, in which: [0021]
  • FIG. 1 schematically illustrates a CVD apparatus in accordance with the present invention; [0022]
  • FIG. 2 depicts the relationship between the number of process cycles and the content of impurities included in an amorphous tantalum oxide film; [0023]
  • FIG. 3 presents the relationship between the number of process cycles and a leak current of a crystallized tantalum oxide film; [0024]
  • FIG. 4 schematically represents a substrate processing apparatus in accordance with the present invention; [0025]
  • FIG. 5 schematically shows a conventional CVD apparatus; [0026]
  • FIG. 6 sets forth a cross sectional view of a tantalum oxide film grown on a substrate; [0027]
  • FIG. 7 shows the relationship between the step coverage and the film growth temperature; [0028]
  • FIG. 8 depicts the relationship between the film growth temperature and the content of impurities included in a tantalum oxide film; and [0029]
  • FIG. 9 schematically shows a conventional substrate processing apparatus.[0030]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • FIG. 1 schematically illustrates a [0031] CVD apparatus 10 in accordance with the present invention. As shown in FIG. 1, a heater 32 is installed in a reactor chamber (hereinafter also referred to as a processing chamber) 31. A substrate rotating unit 33 is installed outside the processing chamber 31. A susceptor 34 rotated by the substrate rotating unit 33 is installed in the processing chamber 31. The susceptor 34 is positioned on the heater 32.
  • Further, a [0032] substrate 35, e.g., wafer, is loaded on the susceptor 34. A shower head 36 having shower holes 37 is installed above the susceptor 34. A reactive gas supply unit 38 is installed outside the processing chamber 31. A gas supply line 39 connects the reactive gas supply unit 38 to the shower head 36 and has a valve 40. A reactive gas is supplied to the processing chamber 31 via shower holes 37 after passing through the gas supply line 39 and the shower head 36.
  • Further, a RPO unit (plasma generating apparatus) [0033] 41 is installed outside the processing chamber 31. A gas supply line 42 connects the RPO unit 41 with the shower head 36 and has a valve 43. Also, an exhaust line (exhaust port) 44 is installed at lower side wall of the processing chamber 31.
  • Additionally, a [0034] control unit 45 is provided outside the processing chamber 31. The control unit 45 serves to control the CVD apparatus 10 to repeatedly perform process cycles of a film forming process and a RPO process as many times as desired in the processing chamber 31. During the film forming process, an amorphous (non-crystalline) tantalum oxide film is grown on the substrate 35 and during the RPO process, specific elements such as carbon and hydrogen included in the thus grown amorphous tantalum oxide film are removed or reduced in their amount by the plasma process through the use of the RPO unit 41.
  • Referring to FIG. 1, there will be described a method for manufacturing a semiconductor device and processing a substrate by using the [0035] CVD apparatus 10 in accordance with the present invention. First, the substrate 35 is loaded on the susceptor. 34 positioned in the processing chamber 31. The susceptor 34 is then rotated by the substrate rotating unit 33 and the substrate 35 is heated at about 440° C. by the heater 32. While the substrate 35 is rotated and heated at about 440° C., the valve 40 is opened to supply the substrate 35 with a reactive gas containing the mixture of an evaporated PET, an oxygen gas and an inert gas via the gas supply line 39 and the shower head 36, thereby forming an amorphous tantalum oxide film having a thickness of about 20 Å grown on the substrate 35 (film growing process).
  • Subsequently, the [0036] valve 40 is closed to stop the reactive gas supply while maintaining the same condition in which the substrate 35 is rotated and heated at about 440° C. Thereafter, the valve 43 is opened to introduce oxygen radicals generated from the RPO unit 41 on the substrate 35 though the gas supply line 42 and the shower head 36 to thereby carry out the RPO process on the thus grown amorphous tantalum oxide film (impurity removing process). Consequently, the film growing process and the impurity removing process are sequentially carried out in one processing chamber, i.e., the processing chamber 31.
  • Further, it is preferable that both the film growing process and the impurity removing process are carried out at a substantially same temperature. That is to say, it is preferable that the setting temperature of the heater is maintained constant during the film growing process and the impurity removing process as well. By maintaining a constant temperature or greatly reducing a temperature variation in the processing chamber, particle generation due to thermal expansion of such parts as the shower head or the susceptor in the processing chamber can be suppressed and metal contamination originating from a metallic part in the processing chamber can also be prevented. In view of particulate generation discussed above, it is also preferable that both the film growing process and the impurity removing process are carried out at a constant pressure. [0037]
  • An amorphous tantalum oxide film having a thickness of about 80 Å can be formed by repeatedly performing four times the process cycle where one film forming process and one RPO process are carried out sequentially. That is, the film growing process and the impurity removing process are sequentially repeated a predetermined number of times by controlling the [0038] valves 40, 43 through the use of the control unit 45. Thereafter, the thus processed amorphous tantalum oxide film is treated to provide a crystalline tantalum oxide film by carrying out a RTO process thereon in a RTO process unit (not shown).
  • In the method and apparatus for manufacturing the semiconductor device and processing the substrate, the RPO process is carried out on the amorphous tantalum oxide film having a thickness of 20 Å, i.e., a quarter of the final thickness of 80 Å. Since such impurities as C and H can be removed or reduced more rapidly and uniformly from a thinner film by the RPO process, the amorphous tantalum oxide film having a predetermined final thickness with a low impurity content can be efficiently obtained by repeatedly performing the process cycles as described above. [0039]
  • Some of the advantages obtainable by repeatedly performing the film growing process and the impurity removing process will now be described. In case a thick amorphous tantalum oxide film having a thickness of, e.g., 80 Å with a good step coverage is formed on a substrate having a deep recess or groove, a large amount of impurities is included in the film due to its large thickness. Therefore, if the RPO process is carried out thereon, a possibility that the oxygen radicals are consumed by the reaction with the impurities included in the amorphous tantalum oxide film located at the entrance and the side wall of the deep groove is increased. Accordingly, the impurities such as C and H cannot be uniformly removed in a short time since sufficient oxygen radicals may not be provided to the amorphous tantalum oxide film formed at the bottom of the deep groove. [0040]
  • On the other hand, since the amorphous tantalum oxide film is thin and therefore has a reduced amount of impurities, when the RPO process is performed on the amorphous tantalum oxide film having the thickness of 20 Å, i.e., a quarter of the final thickness 80 Å, less oxygen radicals are consumed at the entrance and the side wall of the groove, so that the sufficient amount of oxygen radicals can be uniformly supplied to the amorphous tantalum oxide film located at the bottom portion of the deep groove. As a result, the amorphous tantalum oxide film having a predetermined target thickness with a low impurity concentration of C, H and the like can be readily formed since the impurities can be uniformly removed in a short time. [0041]
  • During the film growing process, the amorphous tantalum oxide film is also formed on an inner wall of the [0042] processing chamber 31 and the shower head 36. And as the film growing processes are repeated, the thickness of the accumulated film thereon becomes greater and so does the impurities such as C and H included in the accumulated film. As a result, more impurities are introduced in an amorphous tantalum oxide grown later, resulting in temporal variations in the amount of impurities contained in the amorphous tantalum oxide film formed on the substrate 35.
  • In contrast, since the growing process and the RPO process are carried out in a cyclic manner in the same processing chamber in accordance with the present invention, the impurities included in the thin film previously deposited outside the substrate can also be immediately removed by the subsequent RPO process. Resultantly, accumulation of the impurities in the ever thickening TaO film deposited inside the processing chamber can be effectively prevented and a content of the impurities included in the amorphous tantalum oxide film formed on the [0043] substrate 35 can be maintained rather uniformly, without suffering from temporal variations.
  • Instead of the CVD technique disclosed above, an ALD (atomic layer deposition) scheme can be employed, in forming the amorphous tantalum film on the substrate. The ALD differs from the conventional CVD in that in ALD atomic layers are formed one at a time at a lower substrate treating temperature (300° C. or below) and under a low inner pressure inside the processing chamber (10 Pa or below) and further only a surface reaction (adsorption reaction) is taking place. On the other hand, in the method and apparatus for manufacturing a semiconductor device and processing a substrate described above, the amorphous tantalum oxide film is formed by simultaneously growing tens of atomic layers, wherein the treating temperature of the [0044] substrate 35 is high (around 440° C.) and also the inner pressure of the processing chamber 31 is high (50 Pa or above) and further both the surface reaction and a vapor phase reaction are taking place. Further, since the film growing process and the impurities removing process are carried out with the substrate 35 being rotated, the film growth and the removal of the impurities can be uniformly accomplished throughout the substrate 35. Therefore, both the amorphous and the crystalline tantalum oxide film with the uniform film quality and low impurity concentration can be formed on the substrate 35. Also, it is possible to efficiently remove the impurities from the amorphous tantalum oxide film without incurring any damage thereon since the impurity removing process is carried out by using the RPO process.
  • Further, the crystallization process is carried out on the amorphous tantalum oxide film formed on the [0045] substrate 35 obtained by repeatedly performing the film forming process and the impurity removing process sequentially multiple times. Therefore, the crystalline tantalum oxide film having a good step coverage along with a low impurity concentration and good insulating properties can be efficiently formed on the substrate 35. Further, the amorphous tantalum oxide film can be efficiently crystallized since the RTO process is employed in the crystallization process.
  • FIG. 2 depicts a relationship between the number of process cycles and the total amount of impurities included in a crystalline tantalum oxide film, wherein in each process cycle one amorphous tantalum oxide film growing process and one RPO process have been sequentially carried out in the CVD apparatus described in FIG. 1. As shown in FIG. 2, the content of impurities included in the crystalline tantalum oxide film decreases as the number of process cycles increases. [0046]
  • FIG. 3 presents a relationship between the number of process cycles and a leak current (A/cm [0047] 2) of a crystallized tantalum oxide film. The leak current of the crystalline tantalum oxide film decreases as shown in FIG. 3 and the insulating properties thereof become improved as the number of process cycles increases.
  • Referring to FIG. 4, there is illustrated a [0048] substrate processing apparatus 40 in accordance with the present invention, including a load lock chamber 51, a substrate transfer chamber 55, CVD processing chambers 52 and 53 identical to that described in FIG. 1 and a RTO processing chamber 54. Arrows represent various substrate transfer paths.
  • In the [0049] substrate processing apparatus 40, the substrate 35 is transferred from the load lock chamber 51 to the CVD processing chamber 52 or 53, wherein the amorphous tantalum oxide film is formed on the substrate 35 by repeating the amorphous tantalum oxide film growing process and the RPO process sequentially a number of times. Thereafter, the substrate 35 having the amorphous tantalum oxide film thereon is transferred from the CVD processing chamber 52 or 53 to the RTO processing chamber 54. After carrying out the RTO process in the RTO processing chamber 54, the substrate 35 is taken out from the substrate processing apparatus 50 via the load lock chamber 51.
  • In such a [0050] substrate processing apparatus 40, the amorphous tantalum oxide film having a low impurity content of C, H and the like is formed on the substrate 35 by repeatedly performing the process cycles, in which the amorphous tantalum oxide film forming process and the RPO process are sequentially carried out multiple times. Further, the number of transfer processes per each substrate is three in the preferred substrate processing apparatus 40 shown in FIG. 4, while same is four in the conventional substrate processing apparatus 90 shown in FIG. 9. Therefore, the system efficiency and the throughput of product in accordance with the present invention can be improved, in comparison with the prior art substrate processing apparatus. Although the preferred embodiment of the present invention has been described with respect to the tantalum oxide film formed on the substrate 35 by using an organic liquid material, e.g., PET, the present invention can also be applied in cases where other types of films are formed on a substrate by using other types of source materials.
  • The present invention can be advantageously applied to the case where an organic material is used as the source material of a film since the amount of impurities introduced in the grown film becomes large by the use of the organic material. [0051]
  • Further, it is to be appreciated that other plasma process than the RPO process described above can also be employed in the impurity removing process. [0052]
  • Also, other crystallization process than the RTO process described in the preferred embodiment of the invention can also be equally employed in the crystallization process of the film. [0053]
  • While the present invention has been described with respect to certain preferred embodiments only, other modifications and variations may be made without departing from the sprit and scope of the present invention as set forth in the following claims. [0054]

Claims (10)

What is claimed is:
1. A method for manufacturing a semiconductor device, comprising the steps of:
(a) forming an amorphous film on a substrate;
(b) removing at least a portion of an impurity element included in the amorphous film; and
(c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
2. The method of claim 1, wherein the forming step (a) and the removing step (b) are carried out in a same reaction chamber.
3. The method of claim 2, wherein the forming step (a) and the removing step (b) are carried out at the same temperature.
4. The method of claim 1, wherein the removing step (b) is carried out while rotating the substrate.
5. The method of claim 1, wherein the amorphous film is an amorphous tantalum oxide film.
6. The method of claim 1, wherein the removing step (b) is carried out by a plasma process.
7. The method of claim 1, further comprising, after the step (c), the step (d) of performing a crystallization process to crystallize the non-crystalline film formed on the substrate.
8. The method of claim 7, wherein the crystallization process is a rapid thermal oxidation process.
9. A method for processing a substrate, comprising the steps of:
(a) forming an amorphous film on a substrate;
(b) removing at least a portion of an impurity element included in the amorphous film; and
(c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
10. A substrate processing apparatus, comprising:
a processing chamber for processing a substrate;
a gas supply unit for providing a reactive gas into the processing chamber;
a plasma generation unit; and
a control unit,
wherein the control unit controls the substrate processing apparatus to sequentially repeat, in the processing chamber, a film forming process for depositing an amorphous film on the substrate through the use of the reactive gas and a plasma process for removing at least a portion of an impurity element included in the amorphous film through the use of the plasma generation unit.
US10/106,234 2001-06-21 2002-03-27 Method and apparatus for manufacturing a semiconductor device and processing a substrate Abandoned US20020197828A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001187468A JP2003007697A (en) 2001-06-21 2001-06-21 Method for manufacturing semiconductor device, method and apparatus for processing substrate
JP2001-187468 2001-06-21

Publications (1)

Publication Number Publication Date
US20020197828A1 true US20020197828A1 (en) 2002-12-26

Family

ID=19026751

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/106,234 Abandoned US20020197828A1 (en) 2001-06-21 2002-03-27 Method and apparatus for manufacturing a semiconductor device and processing a substrate
US10/109,216 Expired - Lifetime US6687050B2 (en) 2001-06-21 2002-03-28 Amplifier gain error

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/109,216 Expired - Lifetime US6687050B2 (en) 2001-06-21 2002-03-28 Amplifier gain error

Country Status (4)

Country Link
US (2) US20020197828A1 (en)
JP (1) JP2003007697A (en)
KR (1) KR20020096860A (en)
TW (1) TW577123B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191426A1 (en) * 2003-03-26 2004-09-30 Anelva Corporation Film-forming method for forming metal oxide on substrate surface
US20130078789A1 (en) * 2011-09-22 2013-03-28 Hitachi Kokusai Electric Inc. Substrate Processing Apparatus, Method of Manufacturing Semiconductor Device and Non-Transitory Computer-Readable Recording Medium
CN104233227A (en) * 2014-09-23 2014-12-24 上海华力微电子有限公司 Atomic layer deposition equipment and method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6917731B2 (en) * 2002-03-27 2005-07-12 Corning Incorporated Optical amplification module
JP4911984B2 (en) * 2006-02-08 2012-04-04 東京エレクトロン株式会社 Gas supply apparatus, substrate processing apparatus, gas supply method, and shower head

Citations (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034394A (en) * 1988-06-27 1991-07-23 Burroughs Wellcome Co. Therapeutic nucleosides
US5232928A (en) * 1989-07-25 1993-08-03 Boehringer Ingelheim Pharmaceuticals, Inc. Tetrahydroisoquinoline amides
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20030236242A1 (en) * 2000-04-03 2003-12-25 Robert Perni Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
US20040229848A1 (en) * 2003-05-05 2004-11-18 Hans-Ulrich Demuth Glutaminyl based DP IV-inhibitors
US20040259804A1 (en) * 1998-10-22 2004-12-23 Karanewsky Donald S. (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
US6867303B2 (en) * 2002-10-15 2005-03-15 Boehringer Ingelheim International Gmbh Ruthenium complexes as (pre)catalysts for metathesis reactions
US20050119189A1 (en) * 2003-09-18 2005-06-02 Cottrell Kevin M. Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
US20050192212A1 (en) * 2004-01-21 2005-09-01 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis C virus
US20050197301A1 (en) * 2004-02-27 2005-09-08 Schering Corporation 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
US20050209135A1 (en) * 2004-03-15 2005-09-22 Boehringer Ingelheim International Gmbh Process for preparing macrocyclic compounds
US20050215513A1 (en) * 2003-04-25 2005-09-29 Boojamra Constantine G Antiviral phosphonate analogs
US20050267151A1 (en) * 2004-05-25 2005-12-01 Boehringer Ingelheim International Gmbh Process for preparing acyclic HCV protease inhibitors
US20060019905A1 (en) * 2004-07-20 2006-01-26 Boehringer Ingelheim International Gmbh Hepatitis C inhibitor peptide analogs
US20060063915A1 (en) * 2004-09-17 2006-03-23 Boehringer Ingelheim International Gmbh Ring-closing metathesis process in supercritical fluid
US20060069099A1 (en) * 2004-06-28 2006-03-30 Zice Fu Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
US20060198824A1 (en) * 2005-03-02 2006-09-07 Schering Corporation Treatments for flaviviridae virus infection
US20060269516A1 (en) * 2005-05-26 2006-11-30 Schering Corporation Interferon-IgG fusion
US20060276405A1 (en) * 2005-06-02 2006-12-07 Schering Corporation Methods for treating hepatitis C
US20060275366A1 (en) * 2005-06-02 2006-12-07 Schering Corporation Controlled-release formulation
US20070010455A1 (en) * 2005-07-11 2007-01-11 Piyasena Hewawasam Hepatitis C virus inhibitors
US20070027071A1 (en) * 2005-07-20 2007-02-01 Holloway M K HCV NS3 protease inhibitors
US20070032433A1 (en) * 2000-07-21 2007-02-08 Schering Corporation Corvas International, Ltd. Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
US20070054842A1 (en) * 2005-07-25 2007-03-08 Blatt Lawrence M Novel macrocyclic inhibitors of hepatitis C virus replication
US20070054864A1 (en) * 2005-06-30 2007-03-08 Michael Graupe HCV Inhibitors
US20070072809A1 (en) * 2005-07-14 2007-03-29 Gilead Sciences, Inc. Antiviral compounds
US7273851B2 (en) * 2003-06-05 2007-09-25 Enanta Pharmaceuticals, Inc. Tri-peptide hepatitis C serine protease inhibitors
US20070299078A1 (en) * 2006-06-26 2007-12-27 Deqiang Niu Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors
US20080014173A1 (en) * 2006-07-11 2008-01-17 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
US20080107623A1 (en) * 2006-11-01 2008-05-08 Bristol-Myers Squibb Company Inhibitors of Hepatitis C Virus
US7378422B2 (en) * 2003-09-05 2008-05-27 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
US20080125444A1 (en) * 2006-06-06 2008-05-29 Ying Sun Acyclic oximyl hepatitis c protease inhibitors
US7399749B2 (en) * 2004-05-20 2008-07-15 Schering Corporation Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
US7449591B2 (en) * 2004-01-28 2008-11-11 Boehringer Ingelheim International Gmbh Process of removing transition metals
US7482501B2 (en) * 2005-01-17 2009-01-27 Boehringer Ingelheim International Gmbh Process for continuous ringclosing metathesis in compressed carbondioxide
US7491794B2 (en) * 2003-10-14 2009-02-17 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
US20090048297A1 (en) * 2006-07-13 2009-02-19 Achillion Pharmaceuticals 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
US7494660B2 (en) * 2003-10-27 2009-02-24 Vertex Pharmaceuticals Incorporated HCV NS3-NS4A protease resistance mutants
US20090075869A1 (en) * 2005-05-02 2009-03-19 Holloway M Katharine HCV NS3 protease inhibitors
US20090093533A1 (en) * 2005-10-11 2009-04-09 Leonid Beigelman Compounds and methods for inhibiting hepatitis c viral replication
US20090155209A1 (en) * 2007-05-03 2009-06-18 Blatt Lawrence M Novel macrocyclic inhibitors of hepatitis c virus replication
US20090203008A1 (en) * 2006-06-08 2009-08-13 Ludmerer Steven W Rapid method to determine inhibitor sensitivity of NS3/4A protease sequences cloned from clinical samples
US20090269305A1 (en) * 2008-04-15 2009-10-29 Intermune, Inc. Novel macrocyclic inhibitors of hepatitis c virus replication
US20090297476A1 (en) * 2007-05-10 2009-12-03 Intermune, Inc. Novel peptide inhibitors of hepatitis c virus replication

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09321701A (en) * 1996-05-31 1997-12-12 Fujitsu Ltd Optical communication system and optical amplifier
KR100292218B1 (en) * 1997-11-25 2001-07-12 황 철 주 Method of fabricating semiconductor device
JP4005646B2 (en) * 1998-02-06 2007-11-07 富士通株式会社 Optical amplifier and excitation light source control method in optical amplifier
KR100324718B1 (en) * 1998-06-10 2002-02-28 황 철 주 Method for fabricating semiconductor devices
KR100338815B1 (en) * 1999-10-05 2002-05-31 박종섭 Method For Forming The Tantalum Oxide Layer Capacitor
KR100390831B1 (en) * 2000-12-18 2003-07-10 주식회사 하이닉스반도체 Method for forming Ta2O5 dielectric layer by Plasma Enhanced Atomic Layer Deposition

Patent Citations (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034394A (en) * 1988-06-27 1991-07-23 Burroughs Wellcome Co. Therapeutic nucleosides
US5232928A (en) * 1989-07-25 1993-08-03 Boehringer Ingelheim Pharmaceuticals, Inc. Tetrahydroisoquinoline amides
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20040259804A1 (en) * 1998-10-22 2004-12-23 Karanewsky Donald S. (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
US20030236242A1 (en) * 2000-04-03 2003-12-25 Robert Perni Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
US20070032433A1 (en) * 2000-07-21 2007-02-08 Schering Corporation Corvas International, Ltd. Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
US6867303B2 (en) * 2002-10-15 2005-03-15 Boehringer Ingelheim International Gmbh Ruthenium complexes as (pre)catalysts for metathesis reactions
US20050215513A1 (en) * 2003-04-25 2005-09-29 Boojamra Constantine G Antiviral phosphonate analogs
US20040229848A1 (en) * 2003-05-05 2004-11-18 Hans-Ulrich Demuth Glutaminyl based DP IV-inhibitors
US7273851B2 (en) * 2003-06-05 2007-09-25 Enanta Pharmaceuticals, Inc. Tri-peptide hepatitis C serine protease inhibitors
US7378422B2 (en) * 2003-09-05 2008-05-27 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
US20050119189A1 (en) * 2003-09-18 2005-06-02 Cottrell Kevin M. Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
US7491794B2 (en) * 2003-10-14 2009-02-17 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
US20090286843A1 (en) * 2003-10-14 2009-11-19 Blatt Lawrence M Macrocyclic compounds as inhibitors of viral replication
US20090105471A1 (en) * 2003-10-14 2009-04-23 Blatt Lawrence M Macrocyclic compounds as inhibitors of viral replication
US20090111982A1 (en) * 2003-10-14 2009-04-30 Blatt Lawrence M Macrocyclic compounds as inhibitors of viral replication
US20090111969A1 (en) * 2003-10-14 2009-04-30 Blatt Lawrence M Macrocyclic compounds as inhibitors of viral replication
US7494660B2 (en) * 2003-10-27 2009-02-24 Vertex Pharmaceuticals Incorporated HCV NS3-NS4A protease resistance mutants
US20050192212A1 (en) * 2004-01-21 2005-09-01 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis C virus
US7449591B2 (en) * 2004-01-28 2008-11-11 Boehringer Ingelheim International Gmbh Process of removing transition metals
US20050197301A1 (en) * 2004-02-27 2005-09-08 Schering Corporation 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
US20050209135A1 (en) * 2004-03-15 2005-09-22 Boehringer Ingelheim International Gmbh Process for preparing macrocyclic compounds
US7399749B2 (en) * 2004-05-20 2008-07-15 Schering Corporation Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
US20050267151A1 (en) * 2004-05-25 2005-12-01 Boehringer Ingelheim International Gmbh Process for preparing acyclic HCV protease inhibitors
US20060069099A1 (en) * 2004-06-28 2006-03-30 Zice Fu Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
US20060019905A1 (en) * 2004-07-20 2006-01-26 Boehringer Ingelheim International Gmbh Hepatitis C inhibitor peptide analogs
US20060063915A1 (en) * 2004-09-17 2006-03-23 Boehringer Ingelheim International Gmbh Ring-closing metathesis process in supercritical fluid
US7482501B2 (en) * 2005-01-17 2009-01-27 Boehringer Ingelheim International Gmbh Process for continuous ringclosing metathesis in compressed carbondioxide
US20060198824A1 (en) * 2005-03-02 2006-09-07 Schering Corporation Treatments for flaviviridae virus infection
US20090075869A1 (en) * 2005-05-02 2009-03-19 Holloway M Katharine HCV NS3 protease inhibitors
US20060269516A1 (en) * 2005-05-26 2006-11-30 Schering Corporation Interferon-IgG fusion
US20060275366A1 (en) * 2005-06-02 2006-12-07 Schering Corporation Controlled-release formulation
US20060276405A1 (en) * 2005-06-02 2006-12-07 Schering Corporation Methods for treating hepatitis C
US20070054864A1 (en) * 2005-06-30 2007-03-08 Michael Graupe HCV Inhibitors
US20070010455A1 (en) * 2005-07-11 2007-01-11 Piyasena Hewawasam Hepatitis C virus inhibitors
US20070072809A1 (en) * 2005-07-14 2007-03-29 Gilead Sciences, Inc. Antiviral compounds
US20070027071A1 (en) * 2005-07-20 2007-02-01 Holloway M K HCV NS3 protease inhibitors
US20090148407A1 (en) * 2005-07-25 2009-06-11 Intermune, Inc. Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
US20070054842A1 (en) * 2005-07-25 2007-03-08 Blatt Lawrence M Novel macrocyclic inhibitors of hepatitis C virus replication
US20090093533A1 (en) * 2005-10-11 2009-04-09 Leonid Beigelman Compounds and methods for inhibiting hepatitis c viral replication
US20080125444A1 (en) * 2006-06-06 2008-05-29 Ying Sun Acyclic oximyl hepatitis c protease inhibitors
US20090203008A1 (en) * 2006-06-08 2009-08-13 Ludmerer Steven W Rapid method to determine inhibitor sensitivity of NS3/4A protease sequences cloned from clinical samples
US20070299078A1 (en) * 2006-06-26 2007-12-27 Deqiang Niu Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors
US20080014173A1 (en) * 2006-07-11 2008-01-17 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
US20090048297A1 (en) * 2006-07-13 2009-02-19 Achillion Pharmaceuticals 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
US20080107623A1 (en) * 2006-11-01 2008-05-08 Bristol-Myers Squibb Company Inhibitors of Hepatitis C Virus
US20090155209A1 (en) * 2007-05-03 2009-06-18 Blatt Lawrence M Novel macrocyclic inhibitors of hepatitis c virus replication
US20090297476A1 (en) * 2007-05-10 2009-12-03 Intermune, Inc. Novel peptide inhibitors of hepatitis c virus replication
US20090269305A1 (en) * 2008-04-15 2009-10-29 Intermune, Inc. Novel macrocyclic inhibitors of hepatitis c virus replication

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191426A1 (en) * 2003-03-26 2004-09-30 Anelva Corporation Film-forming method for forming metal oxide on substrate surface
US20090155491A1 (en) * 2003-03-26 2009-06-18 Anelva Corporation Film-forming method for forming metal oxide on substrate surface
US20130078789A1 (en) * 2011-09-22 2013-03-28 Hitachi Kokusai Electric Inc. Substrate Processing Apparatus, Method of Manufacturing Semiconductor Device and Non-Transitory Computer-Readable Recording Medium
CN104233227A (en) * 2014-09-23 2014-12-24 上海华力微电子有限公司 Atomic layer deposition equipment and method

Also Published As

Publication number Publication date
US6687050B2 (en) 2004-02-03
TW577123B (en) 2004-02-21
US20020196531A1 (en) 2002-12-26
JP2003007697A (en) 2003-01-10
KR20020096860A (en) 2002-12-31

Similar Documents

Publication Publication Date Title
US7488386B2 (en) Atomic layer deposition methods and chemical vapor deposition methods
US7112544B2 (en) Method of atomic layer deposition on plural semiconductor substrates simultaneously
US9238257B2 (en) Method of manufacturing semiconductor device, cleaning method, and substrate processing apparatus
US6165916A (en) Film-forming method and film-forming apparatus
US6124158A (en) Method of reducing carbon contamination of a thin dielectric film by using gaseous organic precursors, inert gas, and ozone to react with carbon contaminants
JP5005170B2 (en) Method for forming ultra-high quality silicon-containing compound layer
US20090130331A1 (en) Method of Forming Thin Film and Method of Manufacturing Semiconductor Device
US6656282B2 (en) Atomic layer deposition apparatus and process using remote plasma
JP5376361B2 (en) Method and apparatus for manufacturing tungsten film
KR100539274B1 (en) Method for depositing cobalt layer
US20040152254A1 (en) Method of forming a Ta2O5 comprising layer
JPH10144628A (en) Improved deposition method of thin film
US20050136660A1 (en) Method of forming titanium film by CVD
JP2011168881A (en) Method of manufacturing semiconductor device and substrate processing apparatus
JP2004096060A (en) Film forming method
US7217669B2 (en) Method of forming a metal oxide film
US20020197828A1 (en) Method and apparatus for manufacturing a semiconductor device and processing a substrate
KR101941766B1 (en) Substrate processing method and recording medium
WO2002045147A2 (en) Method for pretreating dielectric layers to enhance the adhesion of cvd metal layers thereto
JP3718297B2 (en) Thin film manufacturing method and thin film manufacturing apparatus
JPH05136087A (en) Method and apparatus for growing film
JP2803556B2 (en) Method of forming barrier metal layer
JP2004296887A (en) Manufacturing method of semiconductor device and substrate treatment equipment
JP5547425B2 (en) Process and apparatus for processing wafers
KR940010412B1 (en) Method of forming thin film

Legal Events

Date Code Title Description
AS Assignment

Owner name: HITACHI KOKUSAI ELECTRIC INC., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ASAI, MASAYUKI;TANAKA, TSUTOMU;REEL/FRAME:012864/0478

Effective date: 20020326

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION